Company
Structure
Structure is a clinical-stage biopharmaceutical company leveraging structure-based drug design to develop more accessible oral small molecule therapeutics for the treatment of chronic diseases including obesity and related diseases.
Also known as Structure Therapeutics
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Legal name
- Structure Therapeutics
- structuretx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Press page (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
Structure is a clinical-stage biopharmaceutical company leveraging structure-based drug design to develop more accessible oral small molecule therapeutics for the treatment of chronic diseases including obesity and related diseases.
Funding snapshot
- Total raised
- $165MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $7M2021-12-15
Funding rounds
- Round, 2021
- $7M2021-12-15, SEC form D sold, 8 investors
- Round, 2021
- $100M2021-07-30, SEC form D sold, 30 investors
- Round, 2020
- $26M2020-03-11, SEC form D sold, 9 investors
- Round, 2019
- $32M2019-04-29, SEC form D sold, 6 investors
Loading relationship preview